Pang‐Bo Li

436 total citations
16 papers, 332 citations indexed

About

Pang‐Bo Li is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Pang‐Bo Li has authored 16 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Cardiology and Cardiovascular Medicine and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Pang‐Bo Li's work include Cardiac Fibrosis and Remodeling (6 papers), ATP Synthase and ATPases Research (4 papers) and Cardiac Ischemia and Reperfusion (4 papers). Pang‐Bo Li is often cited by papers focused on Cardiac Fibrosis and Remodeling (6 papers), ATP Synthase and ATPases Research (4 papers) and Cardiac Ischemia and Reperfusion (4 papers). Pang‐Bo Li collaborates with scholars based in China. Pang‐Bo Li's co-authors include Hui‐Hua Li, Xiao Han, Xiao Yan, Shubin Guo, Yun‐Long Zhang, Jing Gao, Jie Yang, Yunlong Zhang, Chunmin Li and Chen Chen and has published in prestigious journals such as Hypertension, Cellular and Molecular Life Sciences and Nutrients.

In The Last Decade

Pang‐Bo Li

15 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pang‐Bo Li China	12	197	104	74	48	47	16	332
Ruiyu Wang China	14	169 0.9×	76 0.7×	65 0.9×	32 0.7×	43 0.9×	42	379
Chuansheng Xu China	10	202 1.0×	126 1.2×	63 0.9×	26 0.5×	30 0.6×	16	401
Ku-Geng Huo Canada	8	169 0.9×	85 0.8×	67 0.9×	25 0.5×	54 1.1×	13	425
Huibo Wang China	8	163 0.8×	80 0.8×	37 0.5×	76 1.6×	25 0.5×	13	321
Yingmei Zhang China	10	220 1.1×	71 0.7×	32 0.4×	57 1.2×	40 0.9×	16	413
Shengqi Huo China	9	186 0.9×	52 0.5×	62 0.8×	51 1.1×	101 2.1×	17	396
Zifan Zeng China	12	189 1.0×	94 0.9×	44 0.6×	27 0.6×	67 1.4×	25	362
Silin Lv China	11	209 1.1×	61 0.6×	105 1.4×	37 0.8×	76 1.6×	20	404
Wenxin Kou China	10	157 0.8×	69 0.7×	87 1.2×	64 1.3×	36 0.8×	21	355

Countries citing papers authored by Pang‐Bo Li

Since Specialization

Citations

This map shows the geographic impact of Pang‐Bo Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pang‐Bo Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pang‐Bo Li more than expected).

Fields of papers citing papers by Pang‐Bo Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pang‐Bo Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pang‐Bo Li. The network helps show where Pang‐Bo Li may publish in the future.

Co-authorship network of co-authors of Pang‐Bo Li

This figure shows the co-authorship network connecting the top 25 collaborators of Pang‐Bo Li. A scholar is included among the top collaborators of Pang‐Bo Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pang‐Bo Li. Pang‐Bo Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Li, Pang‐Bo, et al.. (2025). Proteasome-activating peptide 1 attenuates cardiac ischaemia/reperfusion-induced ferroptosis through the β5i-p53-SLC7A11 axis. Biomedicine & Pharmacotherapy. 189. 118296–118296.

Li, Pang‐Bo, et al.. (2024). The mechanosensitive Piezo1 channel exacerbates myocardial ischaemia/reperfusion injury by activating caspase-8-mediated PANoptosis. International Immunopharmacology. 139. 112664–112664. 27 indexed citations

Li, Pang‐Bo, et al.. (2024). Psmb8 inhibits mitochondrial fission and alleviates myocardial ischaemia/reperfusion injury by targeting Drp1 degradation. Cell Death and Disease. 15(11). 803–803. 2 indexed citations

Li, Pang‐Bo, et al.. (2023). Ursolic Acid Ameliorates Myocardial Ischaemia/Reperfusion Injury by Improving Mitochondrial Function via Immunoproteasome-PP2A-AMPK Signalling. Nutrients. 15(4). 1049–1049. 25 indexed citations

Gao, Jing, et al.. (2023). TCH-165 attenuates cardiac ischaemia/reperfusion injury by balancing mitochondrial dynamics via increasing proteasome activity. European Journal of Pharmacology. 957. 176011–176011. 11 indexed citations

Li, Pang‐Bo, et al.. (2023). N-arachidonoylphenolamine alleviates ischaemia/reperfusion-induced cardiomyocyte necroptosis by restoring proteasomal activity. European Journal of Pharmacology. 963. 176235–176235. 8 indexed citations

Li, Pang‐Bo, et al.. (2023). The immunoproteasome subunit β2i ameliorates myocardial ischemia/reperfusion injury by regulating Parkin-Mfn1/2-mediated mitochondrial fusion. Cellular and Molecular Life Sciences. 80(8). 231–231. 12 indexed citations

Li, Pang‐Bo, et al.. (2023). MK-886 protects against cardiac ischaemia/reperfusion injury by activating proteasome-Keap1-NRF2 signalling. Redox Biology. 62. 102706–102706. 33 indexed citations

Zhang, Yunlong, Pang‐Bo Li, Xiao Han, Bo Zhang, & Hui‐Hua Li. (2022). Blockage of Fibronectin 1 Ameliorates Myocardial Ischemia/Reperfusion Injury in Association with Activation of AMP‐LKB1‐AMPK Signaling Pathway. Oxidative Medicine and Cellular Longevity. 2022(1). 6196173–6196173. 21 indexed citations

10.

Yan, Xiao, Yun‐Long Zhang, Xiao Han, et al.. (2022). Time Series Transcriptomic Analysis by RNA Sequencing Reveals a Key Role of PI3K in Sepsis-Induced Myocardial Injury in Mice. Frontiers in Physiology. 13. 903164–903164. 17 indexed citations

11.

Han, Xiao, Yunlong Zhang, Tingting Fu, et al.. (2020). Blockage of UCHL1 activity attenuates cardiac remodeling in spontaneously hypertensive rats. Hypertension Research. 43(10). 1089–1098. 13 indexed citations

12.

Zhang, Yunlong, Fei Teng, Xiao Han, et al.. (2020). Selective blocking of CXCR2 prevents and reverses atrial fibrillation in spontaneously hypertensive rats. Journal of Cellular and Molecular Medicine. 24(19). 11272–11282. 21 indexed citations

13.

Zhang, Yun‐Long, Huajun Cao, Xiao Han, et al.. (2020). Chemokine Receptor CXCR-2 Initiates Atrial Fibrillation by Triggering Monocyte Mobilization in Mice. Hypertension. 76(2). 381–392. 46 indexed citations

14.

Cao, Huajun, Yun‐Long Zhang, Xiao Han, et al.. (2019). Genetic ablation and pharmacological inhibition of immunosubunit β5i attenuates cardiac remodeling in deoxycorticosterone-acetate (DOCA)-salt hypertensive mice. Journal of Molecular and Cellular Cardiology. 137. 34–45. 21 indexed citations

15.

Zhang, Yun‐Long, Jie Yang, Xiao Yan, et al.. (2019). Chronic inhibition of chemokine receptor CXCR2 attenuates cardiac remodeling and dysfunction in spontaneously hypertensive rats. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1865(12). 165551–165551. 38 indexed citations

16.

Chen, Chen, Xiao Yan, Qiu‐Yue Lin, et al.. (2019). Resveratrol Attenuates Pressure Overload‐Induced Cardiac Fibrosis and Diastolic Dysfunction via PTEN/AKT/Smad2/3 and NF‐κB Signaling Pathways. Molecular Nutrition & Food Research. 63(24). e1900418–e1900418. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact